SRNE's free cash flow for Q was $-65.01M. For the fiscal year, SRNE's free cash flow was decreased by $-124.63M and operating cash flow was $-61.17M. See a summary of the company’s cash flow.

Cash Flow	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Operating Cash Flow	$ -297.66M	$ -281.82M	$ -159.54M	$ -173.00M	$ -111.77M	$ -99.18M
Investing Cash Flow	$ -25.69M	$ 79.85M	$ -39.92M	$ -38.17M	$ -21.20M	$ -16.53M
Financing Cash Flow	$ 357.50M	$ 181.33M	$ 174.24M	$ 78.89M	$ 326.00M	$ 53.67M
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	$ 289.60M	$ 36.66M	$ 56.46M	$ 80.77M	$ 213.33M	$ 20.43M
Income Tax Paid Supplemental Data	$ 29.00K	$ 1.20M	$ 0.00	$ 13.00K	$ 6.00K	$ 34.00K
Interest Paid Supplemental Data	$ 1.64M	$ 1.06M	$ 3.42M	$ 12.74M	$ 1.62M	$ 3.50M
Issuance Of Capital Stock	$ 406.98M	$ 201.82M	$ 317.87M	$ 47.70M	$ 83.61M	$ 57.93M
Issuance Of Debt	$ 113.25M	$ 49.74M	$ 18.59M	$ 25.41M	$ 284.64M	$ 49.92M
Repayment Of Debt	$ -165.73M	$ -85.66M	$ -205.56M	$ -3.07M	$ -42.47M	$ -53.16M
Free Cash Flow	$ -309.00M	$ -290.69M	$ -166.06M	$ -184.44M	$ -122.96M	$ -110.15M
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in USD

Sorrento Therapeutics Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing